Apama Medical is a privately held medical device company based in Campbell, CA, focused on next‑generation atrial fibrillation technologies. It offers a catheter-based solution for AF ablation targeted at the electrophysiology market. The company was incubated out of Shifamed, LLC and is supported by an existing National Science Foundation grant. Leadership includes CEO Amr Salahieh and Executive Chairman Gregory D. Casciaro. The article notes the electrophysiology market for AF ablation was expected to reach $1.7 billion in 2017. Financially, Apama closed an $11.0M first tranche of a planned $17.5M Series B financing, and investor representatives will join the board.

Total raised

$11M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2015